Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: LncRNA Nicotinamide Nucleotide Transhydrogenase-Antisense RNA1 NNT-AS1 in CRC

View source ↗

Summary

A completed clinical trial investigating the lncRNA NNT-AS1 antisense RNA1 in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NNT-AS1 antisense RNA1 (NNT-AS1 antisense RNA1)

Snippet

Sponsor: Ain Shams University | Conditions: Colorectal Cancer | Status: COMPLETED